Outcomes of Autologous Stem Cell Transplantation for Lymphoma in the Elderly: A Single Center Experience
Year: 2016
Type: article
Study design: Observational Study
Abstract: Autologous stem cell transplant (ASCT) is a potentially curative option for lymphoma, yet there remains a bias against offering this therapy to the elderly. Patients above age 65 are nearly always excluded from ASCT clinical trials, limiting our understanding of the efficacy and transplant related mortality (TRM) in this population. This lack of data and bias against ASCT in the elderly may delay referral for patients who may benefit from a transplant. Here, we report outcomes from patients aged 65 and greater who underwent autologous stem cell transplant for lymphoma at our institution.
Institution: University of Kansas Medical Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2510378698